Fig. 3.
Perspectives for application of the organoid-based liver models. Stem cells or patient’s sample-derived cells can be generated into various organoid-based liver models such as cancer, disease, and normal liver. Normal models can be used as candidates for regenerative medicine, and cancer and disease models can be applied for drug screening and evaluation